Table 1

 Characteristics of studies included in the review

AuthorsType of surgeryNo. of patientsPreoperative smoking cessation periodLength of follow-upClear definition of period of cessationCessation validatedMain findingsPercentage risk/relative risk
*Information on the total number of participants in each group not provided.
†The exact number of participants in each group does not appear to match the total number in the sample reported.
CI, confidence interval; CS, current smokers; mths, months; PS, past smokers; NS, non- smokers; QPS, quit post-surgery; RR, relative risk; wks, weeks.
Barrera et al, 200530Thoracotomy/ lung cancer resection300PS30 daysYesNoNo significant increase in pulmonary complications among those who quit within 2 months and CS. Incidence of pneumonia was lower in NS compared to PS or CS but there was no significant difference between PS and CS Total complications
300<2 mths (13%)PS  = 19%
>2 mths (62%)RQ  = 23%
CS (4%)NS  = 8%
NS (21%) Pneumonia
PS  = 10%
RQ  = 15%
NS  = 3%
Atelectasis
PS  = 5%
RQ  = 3%
NS  = 0%
Pulmonary embolism
PS  = 2%
RQ  = 3%
NS  = 2%
Respiratory failure
PS  = 1%
RQ  = 3%
NS  = 0%
Mean length of stay
CS  = 9 days
PS  = 8 days
RQ  = 8 days
NS  = 6 days
Bluman et al, 199832General, orthopaedic, cardiac410PS (46%)Not statedYesNoCS had a 6×-increased risk of pulmonary complications. There was no significant increase in risk of pulmonary complications in PS in comparison to NS. Reducing cigarette consumption <1 month preoperatively did not reduce the risk of pulmonary complications Atelectasis or worsening
<1 wkCS  = 8%
⩾1 wk <2 wksPS  = 7%
⩾2 wks <4 wksNS  = 0%
⩾1 mth Pulmonary infection
CS reduced <4 wksCS  = 3% PS  = 1% N
CS (34%)S  = 0%
NS (20%) Mortality
CS  = 1%
PS  = 1%
NS  = 0%
Total PCs (95% CI)
<1 wk  = 3.5%; 10.6 (1.6 to 69.6)
<2 wks  = 7.1%; 4.7 (1.2 to 19.0)
<4 wks  = 7.8%; 4.0 (1.0 to 15.7)
⩾1 mth  = 6.4%; 14.2 (3.2 to 63.6)
CS  = 74.5% 1.0
Chang et al, 200033TRAM flap breast reconstruction718PS ⩽4 wks (67%)Not statedNoNoCS had a higher incidence of complications than NS with no significant differences between NS and PS. Heavier smokers had a higher overall complication risk than lighter smokers Overall flap complication
CS (13%)CS  = 31.1%
NS (67%)PS  = 25.3%
NS  = 22.6%
Goodwin et al, 200534Tissue expander/implant breast reconstruction515PS >4 wks (15%)Not statedNoNoThere were significantly more complications in PS than NS. There was no significant difference in complication rates between PS and CS. There was an 80% increased risk of complications for each pack increase in cigarettes per day Wound infection
CS (11%)CS  = 9.1%
NS (75%)NS  = 2.9%
Total PCs
CS  = 37.9%
NS  = 15.1%
Hasdai et al, 199735Coronary revascularisation5437PS >6 mths (42%)Up to 16 years (average 4.5 years)NoNoLong-term risk of mortality was 44% greater in CS in comparison to PS. Cessation before or after surgery was beneficialMortality QPS  = 1.2 (0.87–1.70)
QPS (8%)PS  = 1.3 (1.14–1.57)
CS (14%)NS  = 1.0
NS (37%) Myocardial infarction
QPS  = 1.4 (0.64 to 3.11)
PS  = 1.28 (0.77 to 2.16)
NS  = 1.0
Severe angina
QPS  = 0.91 (0.76 to 1.08)
PS  = 0.99 (0.90 to 1.09)
NS  = 1.0
Lavernia et al, 199936Unilateral arthroplasty of hip or knee202PS <6 weeksNot statedNoNoNS combined with PS had significantly shorter surgery duration and needed less anaesthesia than CS. NS combined with PS had significantly shorter surgery duration and needed less anaesthesia than CS Length of stay
CS (12%)CS  = 5.4±3.9
NS (88%)PS  = 5.3±2.7
NS  = 5.1±2.6
Total PCs
CS  = 16%
PS  = 26.2%
NS  = 21.5%
Levin et al, 200437Onlay bone grafts, sinus lift128PS >6 mthsNot statedNoNoSignificantly higher incidence of postoperative complications in CS in comparison to NS. No significantly increased risk of complications in PS Total PCs
CS:NS  = 23.1%
Mild <10 per dayCS  = 50%
Heavy ⩾10 per dayNo data obtainable for PS
NS*
Moore et al, 200538Pelvic reconstructive surgery887PS ⩾1 mth (26%)1 mthNoNoNo significant difference in the incidence of postoperative complications in NS and PSTotal PCs PS  = 26%
NS (74%)NS  = 29%
Myles et al, 200239Ambulatory Surgery489PS>28 days (24%)7 daysNoYesPS combined with NS had a significantly lower incidence of coughing, respiratory complications and wound infection than CSRespiratory CS  = 33.5%
CS (41%)PS  = 34.5%
NS (35%)NS  = 25.9%
Wound infection
CS  = 3.7%
PS  = 2.6%
NS  = 0.6%
Warner et al, 198940Coronary artery bypass graft (CABG)192PS (69%)96 daysYesYesSmokers quitting <2 months before surgery had a 4× increased risk of pulmonary complications than those quit >2 months before surgery. Smokers who stopped smoking >6 months before surgery had the same risk of complications as NS Total PCs
<2 mths<2 months  = 57.1%
>2 mths>8 weeks  = 11.8%
CS (9%)>6 months  = 11.1%
NS (22%)CS  = 33%
NS  = 11.9%
Woehlck et al, 199917Non-emergency, non-cardiac and non-major vascular surgery740PS data included in with NS (62%)Not statedNoYesCS had more complications than PS or NS Data unobtainable
CS (37%)†
Yamashita et al, 200441Minor1008PS (37%) <1 wk30 days or up to dischargeYesNoCS and PS significantly more likely to have increased intraoperative sputum volume than NS. No significant differences in postoperative complications between PS, CS and NS Increased sputum; RR (95% CI)
>1 wk <2 wks >2 wks <2 mths<1 wk  = 22.9%; 2.4 (1.6 to 3.6)
>2 mths CS (16%)<2 wks  = 22.9%; 2.4 (1.2 to 4.8)
NS (48%)<2 mths  = 18.8%; 2.0 (0.9 to 4.3)
>2 mths  = 11.0%; 1.2 (0.7 to 2.0)
CS  = 18.2%; 1.9 (1.3 to 3.0)
NS  = 9.3% 1.0
Total PCs
>24 hours  = 1.4%
CS  = 1.9%
NS  = 1.7%